logo
Sign in

INDEGENE LIMITED (INDGN) financials

INDEGENE LIMITED (INDGN) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1998, Indegene Ltd providessolutions consisting of analytics, technologyand commercial, medical, regulatory andsafety services to life science and healthcare organizations[1]

  • Market Cap: ₹13,986Cr.
  • Current Price: ₹580
  • Stock P/E: 61.7
  • ROE: 10.7%
  • ROCE: 14.3%
  • Book Value: ₹86.4
  • Dividend Yield: 0.39%
  • 52W High / Low: ₹627/414

In Jun 2026, INDEGENE LIMITED (INDGN) reported sales ₹341 Cr and net profit ₹60 Cr.

Annual TTM: sales ₹1,306 Cr, net profit ₹227 Cr.

Shareholding: FIIs 12.40% (Sep 2026), DIIs 15.82% (Sep 2026), Public 71.76% (Sep 2026), No. of Shareholders 1,32,280% (Sep 2026).

INDGN quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales282287267256307290368341
Expenses235235227219236252265280
Operating Profit46524037713810360
OPM %16%18%15%14%23%13%28%18%
Other Income222235321823634
Interest22222233
Depreciation66779101111
Profit before tax6166666078499580
Tax %27%25%18%25%23%29%24%25%
Net Profit4550544560357260
EPS in Rs1.872.082.261.882.491.452.992.49
Raw PDF————————
INDGN profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3345118371,0061,0461,0941,2211,306
Expenses2493616688288789139721,034
Operating Profit86150169178168180248272
OPM %26%29%20%18%16%17%20%21%
Other Income-2430283750907880
Interest343676910
Depreciation1318243231263640
Profit before tax46159170177181238281302
Tax %30%17%22%26%24%24%25%—
Net Profit32132133130138181212227
EPS in Rs1.616.695.995.876.207.558.809.42
Dividend Payout %0%0%0%0%0%26%26%—
INDGN balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.310.300.300.4044444848
Reserves158-32546507519091,8402,032
Borrowings106362234451382770
Other Liabilities577296156191228234332
Total Liabilities3224313738501,0381,2202,1502,482
Fixed Assets8314172785653113
CWIP000000412
Investments134251832034006249751,318
Other Assets1801482495755595401,1191,039
Total Assets3224313738501,0381,2202,1502,482
INDGN cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6290533882176129346
Cash from Investing Activity-70-51-34-267-51-189-824-270
Cash from Financing Activity15-18-37245-17-16717-63
Net Cash Flow820-181614-292213
Free Cash Flow6084351766166112302
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit145%122%52%44%70%134%111%159%
INDGN shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
FIIs5.03%5.24%10.04%11.30%11.48%10.27%9.92%12.40%
DIIs3.99%4.96%7.20%6.95%8.06%8.29%8.74%15.82%
Public91.01%89.80%82.75%81.74%80.44%81.43%81.34%71.76%
No. of Shareholders1,53,7891,44,7081,51,9971,51,8091,47,1821,42,1191,38,5331,32,280
INDGN key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days656512515214513214086
Inventory Days————————
Days Payable————————
Cash Conversion Cycle656512515214513214086
Working Capital Days16-127610311310412151
ROCE %—28%49%36%24%18%17%14%
INDGNUpdated 22 Oct 2026, 5:34

Indegene Limited

Market Cap

₹13,986Cr.

Current Price

₹580

High / Low

₹627/414

Stock P/E

61.7

ROE10.7%
ROCE14.3%
Book Value₹86.4
Face Value₹2.00
Dividend Yield0.39%

About

Incorporated in 1998, Indegene Ltd providessolutions consisting of analytics, technologyand commercial, medical, regulatory andsafety services to life science and healthcare organizations[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days656512515214513214086
Inventory Days————————
Days Payable————————
Cash Conversion Cycle656512515214513214086
Working Capital Days16-127610311310412151
ROCE %—28%49%36%24%18%17%14%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of INDEGENE LIMITED (INDGN)?

The reported market capitalisation for INDEGENE LIMITED (INDGN) is ₹13,986Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of INDGN?

The current price shown for INDEGENE LIMITED (INDGN) on Fincrux is ₹580 with a 52-week high/low of ₹627/414.

What is the P/E ratio of INDEGENE LIMITED (INDGN)?

The stock P/E for INDEGENE LIMITED (INDGN) is 61.7 on Fincrux, with ROE at 10.7% and ROCE at 14.3%.

What were INDGN latest quarterly results?

For Jun 2026, INDEGENE LIMITED (INDGN) reported sales ₹341 Cr and net profit ₹60 Cr (figures in ₹ crore unless noted).

What are INDGN annual sales and net profit?

For TTM, INDEGENE LIMITED (INDGN) shows sales of ₹1,306 Cr and net profit of ₹227 Cr on the Fincrux profit & loss statement.

Who owns INDEGENE LIMITED (INDGN)?

Latest shareholding for INDEGENE LIMITED (INDGN) on Fincrux: FIIs 12.40% (Sep 2026), DIIs 15.82% (Sep 2026), Public 71.76% (Sep 2026), No. of Shareholders 1,32,280% (Sep 2026).

Where can I find INDEGENE LIMITED (INDGN) financials?

INDEGENE LIMITED (INDGN) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show INDGN balance sheet and cash flow?

Yes. The INDEGENE LIMITED (INDGN) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 5:34

Designed & Shipped by Harshit Bansal